International Biotechnology Trust’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$3.31M Hold
2023
Q2
$7.3M Buy
2023
Q1
$5.89M Buy
2022
Q4
$2.21M Hold
2022
Q3
$3.24M Buy